The global single-cell omics market comprises technologies and consumables that facilitate the analysis of specific components or entire genomes of individual cells. Single-cell analysis helps elucidate biological heterogeneity that is otherwise averaged out in bulk tissue studies. It is gaining prominence in various disciplines such as immunology, neuroscience, stem cell research and cancer biology.

The Global Single-cell Omics Market is estimated to be valued at US$ 1.63 BN in 2024 and is expected to exhibit a CAGR of 16.% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in The Global Single-Cell Omics Market are Bio-Rad Laboratories Inc., Agilent Technologies Inc., QIAGEN N.V., Thermo Fisher Scientific, Illumina Inc., Roche, Bio-Techne, and Pacific Biosciences. Key players are focusing on partnerships, mergers, acquisitions and new product launches to strengthen their market position. The growing demand for better diagnostic techniques and personalized medicines is driving the adoption of single-cell analysis across various therapeutic areas. Technological advancements including microfluidics-based techniques, next-generation sequencing and advances in bioinformatics are supporting high-throughput analysis of thousands of cells, thus fueling market growth.

Market trends

Emergence of spatial transcriptomics: Techniques for high-resolution spatial mapping of RNA transcripts within tissues and cells are emerging as a key area. This allows correlating the expression of marker genes with cell location and microenvironment. Integration of omics: Players are focusing on integrating multi-omics analysis of DNA, RNA and proteins from the same single cell for comprehensive molecular profiling.

Market Opportunities

Oncology applications: Single-cell analysis finds widespread use in cancer research for studying tumor heterogeneity, detection of rare tumor cells and tracing cell lineage. Growing incidence of cancer will boost opportunity. Non-invasive prenatal testing: Analysis of cell-free DNA from maternal blood samples allows screening for fetal genetic abnormalities non-invasively. This lowers health risks associated with invasive prenatal diagnostics like amniocentesis.

Impact of COVID-19 on Global Single-cell Omics Market Growth

The COVID-19 pandemic has significantly impacted the global Single-cell Omics market. Due to strict lockdowns and movement restrictions imposed worldwide to curb the spread of the virus, research activities and lab experiments slowed down significantly in 2020. This negatively impacted the demand and supply of various omics tools and consumables used in single-cell analysis. Several research projects had to be postponed or delayed which dented the market growth during the initial crisis period. However, the pandemic also highlighted the need for improved diagnostics, virus characterization and vaccine development using advanced single-cell techniques. This led to increased R&D investments in core technologies in subsequent periods. As restrictions eased in late 2020 and 2021, backlogged research work resumed which revived the market to some extent. Going forward, single-cell omics solutions are expected to play a vital role in developing more targeted treatments, antivirals and surveillance initiatives against future pandemics. Researchers are exploring these methods to understand host-pathogen interactions at a deeper level. Overall, while the pandemic posed short term challenges, it also created new opportunities for market growth over the long run.

Geographical Regions with Highest Concentration in Global Single-cell Omics Market

North America accounts for the largest share of the global single-cell omics market in terms of value. Advanced research infrastructure, extensive funding for healthcare and life sciences sectors, and presence of several industry pioneers have cemented North America's leadership position. The US and Canada are home to many top universities with strong single-cell research programs. Europe is another major revenue generator, primarily due to substantial R&D investments by countries like the UK, Germany, France and Italy. Significant government support for innovative omics technologies has boosted adoption. The Asia Pacific region has emerged as the fastest growing market globally. Expanding biotech industry, increasing healthcare spending, and focus on precision medicine are some key growth drivers. Countries such as China, Japan, South Korea and India are rapidly enhancing their omics capabilities.

Fastest Growing Region in Global Single-cell Omics Market

The Asia Pacific region is poised to witness the fastest growth in the global single-cell omics market during the forecast period. This is mainly attributed to the rising healthcare expenditure across populous nations like China and India. Changing demographic patterns with burgeoning aging populations require more personalized treatment approaches. Continuous funding in research infrastructure upgrades and talent development is bridging the technology gap with Western markets. Academic institutes are actively pursuing single-cell collaborations with global leaders. More regional companies are entering the field to cater to the growing local demand as well. Governments are introducing favorable policies and incentives to boost domestic innovation in this domain. All of the above factors indicate immense growth opportunities in the Asia Pacific single-cell omics sector going forward.

Get More Insights On Global Single-Cell Omics Market